Zimbabwe measles outbreak: Death toll tops 700, Vaccination drive ...
Mysterious Death Of COVID Vaccine Creator Sparks Conspiracy Theories
© DIMITAR DILKOFF/AFP/Getty Images A file photo of A healthcare worker administering a dose of Russia's Sputnik V Covid-19 vaccine to a patient at a vaccination centre in the GUM State Department store in Moscow on October 21, 2021 The death of a Russian virologist who helped develop the country's COVID vaccine has sparked conspiracy theories online about the nature of his demise.
Andrey Botikov, one of 18 scientists who developed the Sputnik V vaccine at the Gamaleya National Research Center, was strangled in his Rogova Street home on March 2, Russian news outlet Regnum reported, citing official sources.
While official accounts point towards a domestic altercation, the 47-year-old's death comes amid a string of members of the Russian elite being found dead in mysterious circumstances over the past year, including scientists and businessmen.
The Investigative Committee of Russia (ICR) announced on Friday that it had opened a murder investigation, believing that a 29-year-old man strangled the scientist with a belt during a disagreement before fleeing the scene.
The ICR's Moscow division didn't name Botikov in a statement, but said investigators had identified and located the assailant "in the shortest possible time."
"During the interrogation, he admitted his guilt, he was charged," it added. "Previously, the defendant was prosecuted for committing a serious crime."
The ICR didn't respond to a request by Newsweek about the identification of the victim. It hasn't provided a public update since March 3.
While many reacting to the story on social media suggested that his death may have been premeditated, others jumped on the story to claim he had died as a result of his own vaccine, or because he was planning to speak out about it.
"Was he about to reveal the truth?" Matt Wallace, a crypto influencer, wrote in a tweet that has since been viewed 2.4 million times and received nearly 10,000 retweets.
Meanwhile, WSPN Speculation News claimed Botikov "was shot up with over 40 doses [of the COVID vaccine] in his apartment in northwest Moscow, he is dead but reports say he died covid free!"
"Reportedly he had one too many up his..." wrote Per Ekstrom, above an image of the Sputnik V vaccine.
"Totally normal that Andrey Botikov, the guy who created the first COVID vaax [sic], was found strangled to death," Insurrectionist Barbie, a pejorative term for women with conservative views, tweeted. "Especially in light of everything that is coming out about both the vaax [sic] and the origins of the virus. Nothing to see here."
Last week, FBI director Christopher Wray said that the agency believed it "most likely" that COVID emerged into the human population from a mishap in a Chinese lab. It followed a report that the U.S. Department of Energy had adopted this belief in light of new intelligence.
Botikov worked as a virologist at the Gamaleya National Research Center since 2014, and was part of the team responsible for the nation's vaccine—which Russia claimed had an efficacy at clinical trials of 91 percent, far higher than other vaccines.
However, Russia has faced vaccine hesitancy domestically. Just over 60 percent of Russians have received at least one dose, according to the latest figures by Johns Hopkins University.
Its sales on the international market have been damaged by the rushed vaccine trials and slowness with sharing scientific results with the international community, researchers at the Carnegie Endowment for International Peace have said.
Botikov's apparent death comes just over two weeks after that of Major General Vladimir Makarov, a high-ranking Russian military official who state investigators said took his own life after being relieved of duty.
In late November, the Russian Embassy in Paris confirmed the death of Vyacheslav Taran, a Russian billionaire and founder of Forex Club, in a helicopter crash near his home in southeastern France.
The former head of the Moscow Aviation Institute, Anatoly Gerashchenko, died last year after falling down "several flights of stairs."
Related Articles
Start your unlimited Newsweek trial
Global "Covid-19 Vaccine Market" Highlights 2023-2031: Best Growth Survey
The MarketWatch News Department was not involved in the creation of this content.
Apr 29, 2023 (The Expresswire) -- Global "Covid-19 Vaccine Market" [2023-2031] Research Report furnishes an industry overview, encompassing significant insights, applications, and the industrial chain structure. Furthermore, it presents an elaborate version of the global market, covering development trends, targeted segment analysis, significant locations, and their developmental status. The analysis scrutinizes advanced strategies, plans, assembly methods, and cost structures. The report also encompasses information on import/trade utilities, market statistics, cost, value, income, and gross market productivity. Ask for a Sample Report
The list of TOP KEY PLAYERS in the Covid-19 Vaccine Market Report are-
● CanSinoBio● Medicago● AnGes● CureVac● Zydus Cadila● Valneva● Gamaleya● Genexine● Sinovac● Novavax● Johnson and Johnson● Bharat Biotech● Moderna● AstraZeneca● Heat Biologics● Symvivo● Sinopharm● Gennova● IIBR● INOVIO● GreenLight Biosciences● Pfizer● AIVITA Biomedical● EuBiologics● BioNTech● Serum Institute of India● GlaxoSmithKline
"Global Covid-19 Vaccine Research Observes Global Market Competition by Manufacturer: The study offers critical insights into key players, product information, and production overview, covering manufacturers worldwide. The analysis provides a detailed account of manufacture, pricing,extra margins, and profits."
Get a sample PDF of the report at-https://www.Industryresearch.Biz/enquiry/request-sample/19995841
Covid-19 Vaccine Market Insights and Report Summary:
During the forecast period from 2023 to 2031, the global Covid-19 Vaccine market is expected to experience significant growth. As of 2022, the market is growing at a steady pace and with the increasing implementation of strategies by major players, the market is projected to continue its upward path.
The Covid-19 Vaccine market has witnessed growth from USD million to USD million from 2017 to 2022. With the CAGR, this market is estimated to reach USD million in 2031.
The report focuses on the Covid-19 Vaccine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Covid-19 Vaccine market.
COVID-19 Impact on Covid-19 Vaccine Market Growth: -
COVID-19 Outbreak Has a Significant Impact on the Covid-19 Vaccine Market in 2020: This research thoroughly explores and analyses the Coronavirus's consequences on the Covid-19 Vaccine industry. The Covid-19 Vaccine Research Report also evaluates the pandemic's impact, developing market trends, and possible opportunities in the COVID-19 landscape.
Final Report will add an analysis of the impact of the Russia-Ukraine War and COVID-19 on this Covid-19 Vaccine Industry.
TO KNOW HOW COVID-19 PANDEMIC AND RUSSIA UKRAINE WAR WILL IMPACT THIS MARKET - REQUEST A SAMPLE
Competitive Landscape:
The report provides a detailed analysis of the competitive landscape of the Covid-19 Vaccine market, including the market share of key players, their competitive strategies, and recent developments.
Analysis of the Covid-19 Vaccine Market by Type -
● Messenger RNA (mRNA) Vaccine● Protein Subunit Vaccine● Vector Vaccine
Analysis of the Covid-19 Vaccine Market by Application: -
● Hospitals● Clinics● Vaccination Centers● Academic and Research Centers● Others
Global Covid-19 Vaccine Market Trends and Marketing Channels Analyzed: The report delves into the analysis of market trends, development, and marketing channels in the global Covid-19 Vaccine market. Additionally, the report evaluates the feasibility of new investment projects and provides overall research conclusions.
Get a Sample PDF of the Covid-19 Vaccine Market Report 2031
Some of the Key Elements that a Market Research Report Typically Includes Are:
Executive Summary: An overview of the key findings, conclusions, and recommendations from the report. It also contains an overview of the market, industry, or sector being analyzed, including market size, growth rate, and key trends.
Market Segmentation: A breakdown of the market into different segments based on factors such as product type, products applications, and geographic region.
Competitive Analysis: An analysis of the key players in the market, their market share, competitive strategies, and strengths and weaknesses.
Customer Analysis: An analysis of the customer base, including their preferences, buying behavior, and demographics.
Market Trends: An analysis of current and emerging trends in the market, including technological advancements, changes in customer behavior, and shifts in the competitive landscape.
SWOT Analysis: An analysis of the market's strengths, weaknesses, opportunities, and threats.
Forecasting: A projection of future market trends and growth opportunities.
Important Highlights of the report:
● This research report reveals this business overview, product overview, market share, demand and supply ratio, supply chain analysis, and import/export details ● The industry report captivates different approaches and procedures endorsed by the market key players to make crucial business decisions ● The historical and current data is provided in the report based on which the future projections are made and the industry analysis is performed ● Porter's five forces analysis, value chain analysis, SWOT analysis are some additional important parameters used for the analysis of market growth ● The report provides the clients with the facts and figures about the market on the basis of evaluation of the industry through primary and secondary research methodologiesGet a sample PDF of the report at-https://www.Industryresearch.Biz/enquiry/request-sample/19995841
Regions and Top Countries Data
The report provides a detailed regional analysis of the global Covid-19 Vaccine market, covering the business growth of various sectors at the regional and country levels. It includes country-wise volume analysis and region-wise market size analysis for the historical and forecast periods from 2018 to 2031. Additionally, the report offers insights into the regional dynamics of the Covid-19 Vaccine market, such as drivers, requirements, opportunities, and challenges. It also covers the impact of regulatory laws and policies on market growth in each region, enabling market players to make informed decisions and develop effective business strategies.
Furthermore, the regional analysis presents a competitive landscape of the Covid-19 Vaccine market, highlighting key players' market share and their growth strategies. The report also includes a comparative analysis of various regions based on different parameters such as market size, growth rate, and market attractiveness. This analysis can help companies identify the most lucrative regions for investment and growth.
Major regions covered in the report:
● North America (USA, Canada, Mexico) ● Europe (Germany, UK, France, Russia, Italy, Rest of Europe) ● Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) ● South America (Brazil, Argentina, Columbia, Rest of South America) ● Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)Get a sample PDF of the report at-https://www.Industryresearch.Biz/enquiry/request-sample/19995841
Global Covid-19 Vaccine Market Research Covers Objectives in this Report:
● Study and analyze the global exhaustion of Covid-19 Vaccine by key regions/countries, product type, and product application, covering documented from 2018 and forecast to 2031. ● Understand the structure of the Covid-19 Vaccine market by identifying its various sub-segments. ● Analyze Covid-19 Vaccine in terms of individual growth trends, future prospects, and their offering to the total Covid-19 Vaccine market. ● Provide detailed data on the key factors affect Covid-19 Vaccine market growth, such as growth potential, opportunities, drivers, industry-specific challenges, and risks. ● Mission the use of Covid-19 Vaccine sub-markets, with respect to key regions and their respective countries. ● Analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. ● Strategically profile key players and comprehensively analyze their growth strategies.Covid-19 Vaccine Market - 2023 Analysis Report Covers Answers to your following Questions:
● What are the current global trends in the Covid-19 Vaccine market? Will there be an increase or decline in demand in the upcoming years? ● What is the projected demand for different types of Covid-19 Vaccine products? What are the upcoming trends and applications in the industry? ● What are the estimated projections for the global Covid-19 Vaccine industries in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export? ● How will strategic developments shape the industry in the mid to long-term? ● What factors contribute to the final price of Covid-19 Vaccine products? What raw materials are used in their manufacturing? ● How significant is the opportunity for the Covid-19 Vaccine market? How will the increasing use of Covid-19 Vaccine products in mining affect the overall market growth rate? ● What is the current value of the global Covid-19 Vaccine market, and how much is it worth?Customization of the Report
Certainly. Our report can be customized to meet your specific requirements. We understand that our clients have unique needs and we strive to provide customized, high-quality solutions that enable them to effectively identify market opportunities, overcome challenges, and develop successful strategies to stay ahead in the competitive landscape. With our multi-dimensional and deep-level analysis, we can provide you with the necessary insights to make informed decisions and gain a competitive power
Inquire more and share questions if any before the purchase on this report at - https://www.Industryresearch.Biz/enquiry/pre-order-enquiry/19995841
Major Points from Table of Contents:
1 Covid-19 Vaccine Market Overview1.1 Product Overview and Scope of Covid-19 Vaccine Market1.2 Covid-19 Vaccine Market Segment by Type1.2.1 Global Covid-19 Vaccine Market Sales and CAGR (Percent) Comparison by Type (2017-2031)1.3 Global Covid-19 Vaccine Market Segment by Application1.3.1 Covid-19 Vaccine Market Consumption (Sales) Comparison by Application (2017-2031)1.4 Global Covid-19 Vaccine Market, Region Wise (2017-2031)1.4.1 Global Covid-19 Vaccine Market Size (Revenue) and CAGR (Percent) Comparison by Region (2017-2031)1.4.2 United States Covid-19 Vaccine Market Status and Prospect (2017-2031)1.4.3 Europe Covid-19 Vaccine Market Status and Prospect (2017-2031)1.4.4 China Covid-19 Vaccine Market Status and Prospect (2017-2031)1.4.5 Japan Covid-19 Vaccine Market Status and Prospect (2017-2031)1.4.6 India Covid-19 Vaccine Market Status and Prospect (2017-2031)1.4.7 Southeast Asia Covid-19 Vaccine Market Status and Prospect (2017-2031)1.4.8 Latin America Covid-19 Vaccine Market Status and Prospect (2017-2031)1.4.9 Middle East and Africa Covid-19 Vaccine Market Status and Prospect (2017-2031)1.5 Global Market Size (Revenue) of Covid-19 Vaccines (2017-2031)1.5.1 Global Covid-19 Vaccine Market Revenue Status and Outlook (2017-2031)1.5.2 Global Covid-19 Vaccine Market Sales Status and Outlook (2017-2031)1.6 Influence of Regional Conflicts on the Covid-19 Vaccine Industry1.7 Impact of Carbon Neutrality on the Covid-19 Vaccine Industry
2 Covid-19 Vaccine Market Upstream and Downstream Analysis2.1 Covid-19 Vaccine Industrial Chain Analysis2.2 Key Raw Materials Suppliers and Price Analysis2.3 Key Raw Materials Supply and Demand Analysis2.4 Market Concentration Rate of Raw Materials2.5 Manufacturing Process Analysis2.6 Manufacturing Cost Structure Analysis2.6.1 Labor Cost Analysis2.6.2 Energy Costs Analysis2.6.3 RandD Costs Analysis2.7 Major Downstream Buyers of Covid-19 Vaccine Analysis2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles4 Global Covid-19 Vaccine Market Landscape by Player4.1 Global Covid-19 Vaccine Sales and Share by Player (2017-2022)4.2 Global Covid-19 Vaccine Revenue and Market Share by Player (2017-2022)4.3 Global Covid-19 Vaccine Average Price by Player (2017-2022)4.4 Global Covid-19 Vaccine Gross Margin by Player (2017-2022)4.5 Covid-19 Vaccine Market Competitive Situation and Trends4.5.1 Covid-19 Vaccine Market Concentration Rate4.5.2 Covid-19 Vaccine Market Share of Top 3 and Top 6 Players4.5.3 Mergers and Acquisitions, Expansion
5 Global Covid-19 Vaccine Sales, Revenue, Price Trend by Type5.1 Global Covid-19 Vaccine Sales and Market Share by Type (2017-2022)5.2 Global Covid-19 Vaccine Revenue and Market Share by Type (2017-2022)5.3 Global Covid-19 Vaccine Price by Type (2017-2022)5.4 Global Covid-19 Vaccine Sales, Revenue and Growth Rate by Type (2017-2022)
6 Global Covid-19 Vaccine Market Analysis by Application6.1 Global Covid-19 Vaccine Consumption and Market Share by Application (2017-2022)6.2 Global Covid-19 Vaccine Consumption Revenue and Market Share by Application (2017-2022)6.3 Global Covid-19 Vaccine Consumption and Growth Rate by Application (2017-2022)
7 Global Covid-19 Vaccine Sales and Revenue Region Wise (2017-2022)7.1 Global Covid-19 Vaccine Sales and Market Share, Region Wise (2017-2022)7.2 Global Covid-19 Vaccine Revenue and Market Share, Region Wise (2017-2022)7.3 Global Covid-19 Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)7.4 United States Covid-19 Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)7.5 Europe Covid-19 Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)7.6 China Covid-19 Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)7.7 Japan Covid-19 Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)7.8 India Covid-19 Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)7.9 Southeast Asia Covid-19 Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)7.10 Latin America Covid-19 Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)7.11 Middle East and Africa Covid-19 Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Covid-19 Vaccine Market Forecast (2022-2031)8.1 Global Covid-19 Vaccine Sales, Revenue Forecast (2022-2031)8.1.1 Global Covid-19 Vaccine Sales and Growth Rate Forecast (2022-2031)8.1.2 Global Covid-19 Vaccine Revenue and Growth Rate Forecast (2022-2031)8.1.3 Global Covid-19 Vaccine Price and Trend Forecast (2022-2031)8.2 Global Covid-19 Vaccine Sales and Revenue Forecast, Region Wise (2022-2031)8.2.1 United States Covid-19 Vaccine Sales and Revenue Forecast (2022-2031)8.2.2 Europe Covid-19 Vaccine Sales and Revenue Forecast (2022-2031)8.2.3 China Covid-19 Vaccine Sales and Revenue Forecast (2022-2031)8.2.4 Japan Covid-19 Vaccine Sales and Revenue Forecast (2022-2031)8.2.5 India Covid-19 Vaccine Sales and Revenue Forecast (2022-2031)8.2.6 Southeast Asia Covid-19 Vaccine Sales and Revenue Forecast (2022-2031)8.2.7 Latin America Covid-19 Vaccine Sales and Revenue Forecast (2022-2031)8.2.8 Middle East and Africa Covid-19 Vaccine Sales and Revenue Forecast (2022-2031)8.3 Global Covid-19 Vaccine Sales, Revenue and Price Forecast by Type (2022-2031)8.4 Global Covid-19 Vaccine Consumption Forecast by Application (2022-2031)8.5 Covid-19 Vaccine Market Forecast Under COVID-19
9 Industry Outlook9.1 Covid-19 Vaccine Market Drivers Analysis9.2 Covid-19 Vaccine Market Restraints and Challenges9.3 Covid-19 Vaccine Market Opportunities Analysis9.4 Emerging Market Trends9.5 Covid-19 Vaccine Industry Technology Status and Trends9.6 News of Product Release9.7 Consumer Preference Analysis9.8 Covid-19 Vaccine Industry Development Trends under COVID-19 Outbreak9.8.1 Global COVID-19 Status Overview9.8.2 Influence of COVID-19 Outbreak on Covid-19 Vaccine Industry Development
And more…………
Get a Sample Copy of the Covid-19 Vaccine Report 2023
Key Reasons to Purchase
- To gain insightful analyses of the market and have comprehensive understanding of the global Covid-19 Vaccine Market and its commercial landscape.
- Assess the production processes, major issues, and solutions to mitigate the development risk.
- To understand the most affecting driving and restraining forces in the Covid-19 Vaccine Market and its impact in the global market.
- Learn about the Covid-19 Vaccine Market strategies that are being adopted by leading respective organizations.
- To understand the future outlook and prospects for the Covid-19 Vaccine Market.
- Besides the standard structure reports, we also provide custom research according to specific requirements
Purchase this report (Price 2980 USD for a single-user license)- https://www.Industryresearch.Biz/purchase/19995841
About Us:
Market is changing rapidly with the ongoing expansion of the industry. Advancement in technology has provided today's businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies a head start in planning and an edge over the competitors.Industry Researchis a credible source for gaining the market reports that will provide you with the lead your business needs.
Contact Us:Industry Research BizPhone: US +1 424 253 0807UK +44 203 239 8187Email:sales@industryresearch.BizWeb:https://www.Industryresearch.Biz
Our Other Reports:
Global "Tequila
Global "Western Wear
2023-2029 "Thermal Spray Powder
2023-2030 "Electric Oil Pump
Global Padel Sports
Industrial Sugar
2023-2029 Pulmonary Arterial Hypertension (PAH) Drugs
2023 Sacrificial Anodes
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Global "Covid-19 Vaccine Market" Highlights 2023-2031: Best Growth Survey
COMTEX_431068741/2598/2023-04-29T05:35:19
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.Com. You can also contact MarketWatch Customer Service via our Customer Center.
The MarketWatch News Department was not involved in the creation of this content.
Promising New Malaria Vaccine Has Been Approved In Two Countries, With Others Likely To Follow
Ghana and Nigeria both approved a new malaria vaccine this month — an important step in the fight against a disease that kills more than 600,000 people annually.
At least 10 other African countries are reviewing trial data for the shot, according to the World Health Organization, so more approvals are expected in the coming weeks.
The vaccine, developed by researchers at Oxford University, is the second to become publicly available. The first, a shot called Mosquirix from drugmaker GSK, has been administered through a pilot program in Kenya, Ghana and Malawi since 2019 but is still in limited supply.
The new vaccine is the first malaria shot to be approved in Nigeria, whose deaths from the disease make up 31% of the worldwide total.
"It's good news," said Dyann Wirth, an infectious diseases professor at the Harvard T.H. Chan School of Public Health, adding, "These vaccines can save lives and save hospitalizations, reduce the impact of the disease in the most vulnerable young children."
An estimated 619,000 people died of malaria in 2021, the latest annual total available, and 96% of those deaths occurred in Africa, according to the WHO. The disease is caused by a parasite that spreads to humans through mosquito bites.
Scientists have been researching possible malaria vaccines since the 1960s; Mosquirix took more than 30 years to develop and test. To prevent infection, countries with high rates of malaria mostly rely on mosquito nets, insecticides or antimalarial drugs for children.
Next steps for the new malaria shotThe Oxford vaccine consists of three doses administered every four weeks, followed by a fourth dose a year later. So far, the only peer-reviewed data on it comes from a small trial of 450 infants up to 17 months old in Burkina Faso. Among that group, the shot was found to reduce the risk of malaria by 77%.
Adrian Hill, the vaccine's lead developer and co-director of the Oxford Martin Program on Vaccines, said a Phase 3 trial of 4,800 children up to 3 years old showed similar safety and efficacy. But those findings have not been published in a peer-reviewed journal.
The WHO is still evaluating data on the Oxford vaccine and has not yet recommended it for use. Countries without their own regulatory processes for approving vaccines often defer to the WHO's recommendations, Wirth said, so they may still wait for that.
The WHO said it does not have a specific timeline for its decision.
"Sadly, we're not seeing the urgency that WHO and every other regulator in the planet showed with Covid," Hill said, "which is disappointing, given that there are huge numbers of deaths from malaria in young children in Africa."
The new vaccine could reach more people more quicklyThe WHO's recommendation of Mosquirix in 2021 represented a major milestone, but manufacturing challenges have led to a slow rollout.
In 2015, GSK closed the Belgium plant where the vaccine was produced, and it did not reopen until 2019. Last year was the first in which the plant continuously manufactured the vaccine's antigen — the component that stimulates an immune response.
GSK has asked a company in India, Bharat Biotech, to produce the antigen instead, but that won't happen until 2028.
To date, 1.5 million children have received the Mosquirix shot, according to the WHO. In addition to the three countries already administering it, 11 others have applied to receive doses, the WHO said.
"The demand for this vaccine has been unprecedented, with 29 countries already coming forward to Gavi saying that they would like to introduce this vaccine already," Dr. Mary Hamel, the WHO's team lead for malaria vaccines, said on a media call Wednesday. (Gavi is an international vaccine alliance that partners with the WHO, governments and nonprofit groups.)
"Demand far outstrips the supply that's currently available," Hamel added.
GSK said it expects to have around 4 million doses available later this year, and a total of 18 million by the end of 2025.
But the WHO estimates that 80 to 100 million annual vaccine doses are required to immunize children at risk of malaria.
The Oxford vaccine could help alleviate the shortage. The Serum Institute of India has already committed to produce 20 million doses in the next two months. (The company is manufacturing the doses "at risk," meaning it hasn't made a deal with a buyer yet.)
The Oxford shot is also cheaper, at $3 per dose relative to around $10 for the GSK shot.
How do the two malaria shots compare?Like the Oxford vaccine, Mosquirix consists of four doses. The first three are administered monthly, starting when an infant is 5 months old, followed by the fourth once they reach 15 to 18 months.
In a large-scale trial, three doses of the vaccine reduced the risk of malaria in children by 28% after four years, while four doses had a slightly higher efficacy of 36%.
Hill said the Oxford vaccine's efficacy also wanes over time but was "still very high" after at least 3 1/2 years.
It's possible, though, that the Oxford shot will prove less effective outside of a trial setting, Wirth said, since the study in Burkina Faso largely administered vaccines before the seasonal peak in malaria transmission, which comes in July.
"I expect that, when released at large scale, it will have a similar efficacy to the existing recommended vaccine," she said.
Neither vaccine will eliminate the need for additional measures to keep malaria from spreading, Wirth added.
"Is it a magic bullet? Will the vaccine alleviate the need for bed nets or insecticide spraying? No, definitely not," she said. "The vaccine will also not replace the need for drugs, but it can be added to the existing tools to have greater impact."
Comments
Post a Comment